BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 020177
(330 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 265
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 42 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 98
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 99 KFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQP 157
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 158 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 186
>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 261
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 38 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 94
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 95 KFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQP 153
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 154 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 182
>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
Length = 256
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 33 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 89
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 90 KFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQP 148
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 149 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 177
>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 259
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 36 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 92
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 93 KFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQP 151
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 152 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 180
>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 39 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 95
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 96 KFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQP 154
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 155 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 183
>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 258
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 35 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 91
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 92 KFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQP 150
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 151 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 179
>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 39 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 95
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 96 KFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQP 154
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 155 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 183
>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 260
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 37 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 93
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 94 KFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQP 152
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 153 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 181
>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
Length = 261
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 53/164 (32%), Positives = 76/164 (46%), Gaps = 32/164 (19%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 35 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 91
Query: 132 KMEETVVPSLLDLQVEGAKYIFET------KTIRRMELLVLSVLDWRLRSVTPFSFI--Y 183
K EE P E A++++ T K + RME LVL VL + L + T F+ Y
Sbjct: 92 KFEEIYPP-------EVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQY 144
Query: 184 FFA-----CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
F CK++ F+G LS I +L+Y PS
Sbjct: 145 FLHQQPANCKVESLAMFLGE---------LSLIDADPYLKYLPS 179
>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 260
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 37 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 93
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 94 KFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQP 152
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 153 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 181
>pdb|4BCQ|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 53/164 (32%), Positives = 76/164 (46%), Gaps = 32/164 (19%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 39 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 95
Query: 132 KMEETVVPSLLDLQVEGAKYIFET------KTIRRMELLVLSVLDWRLRSVTPFSFI--Y 183
K EE P E A++++ T K + RME LVL VL + L + T F+ Y
Sbjct: 96 KFEEIYPP-------EVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQY 148
Query: 184 FFA-----CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
F CK++ F+G LS I +L+Y PS
Sbjct: 149 FLHQQPANCKVESLAMFLGE---------LSLIDADPYLKYLPS 183
>pdb|3QHR|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 261
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 54/174 (31%), Positives = 78/174 (44%), Gaps = 22/174 (12%)
Query: 56 PGFDYLTRFQTHSLDASAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNN 115
P Y+ R + S R V W+++V Y T +L+VNY+DRFL S +
Sbjct: 24 PKVGYMKR--QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK 81
Query: 116 GWPWQLLSVACLSLAAKMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRS 175
QL+ A + LA+K EE P + + V + K + RME LVL VL + L +
Sbjct: 82 ---LQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYSKKQVLRMEHLVLKVLAFDLAA 137
Query: 176 VTPFSFI--YFFA-----CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
T F+ YF CK++ F+G LS I +L+Y PS
Sbjct: 138 PTVNQFLTQYFLHLQPANCKVESLAMFLGE---------LSLIDADPYLKYLPS 182
>pdb|4I3Z|B Chain B, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|D Chain D, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 257
Score = 55.8 bits (133), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 35 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 91
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 92 KFEEIYPPEVAEF-VYITDDTYSKKQVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLHLQP 150
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 151 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 179
>pdb|4II5|B Chain B, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|D Chain D, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 258
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 35 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 91
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 92 KFEEIYPPEVAEF-VYITDDTYSKKQVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLHLQP 150
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 151 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 179
>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
Length = 262
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 39 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 95
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 96 KFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQP 154
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 155 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 183
>pdb|1VIN|A Chain A, Bovine Cyclin A3
Length = 268
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 39 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 95
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 96 KFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQP 154
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 155 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 183
>pdb|3DDQ|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
Length = 269
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 39 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 95
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 96 KFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQP 154
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 155 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 183
>pdb|3DDP|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
Length = 268
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 39 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 95
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 96 KFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQP 154
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 155 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 183
>pdb|3BHT|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|B Chain B, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|D Chain D, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|B Chain B, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|D Chain D, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
Length = 262
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 39 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 95
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 96 KFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQP 154
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 155 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 183
>pdb|3DOG|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 264
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 72 SAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAA 131
S R V W+++V Y T +L+VNY+DRFL S + QL+ A + LA+
Sbjct: 39 SMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLVGTAAMLLAS 95
Query: 132 KMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI--YFFA--- 186
K EE P + + V + K + RME LVL VL + L + T F+ YF
Sbjct: 96 KFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQP 154
Query: 187 --CKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
CK++ F+G LS I +L+Y PS
Sbjct: 155 ANCKVESLAMFLGE---------LSLIDADPYLKYLPS 183
>pdb|2B9R|A Chain A, Crystal Structure Of Human Cyclin B1
pdb|2B9R|B Chain B, Crystal Structure Of Human Cyclin B1
Length = 269
Score = 48.1 bits (113), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 29/105 (27%), Positives = 53/105 (50%), Gaps = 4/105 (3%)
Query: 78 VAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAAKMEETV 137
+ W+++VQ + L T Y++V+ +DRF+ + +P QL+ V + +A+K EE
Sbjct: 42 IDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNSVPKKM---LQLVGVTAMFIASKYEEMY 98
Query: 138 VPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI 182
P + D + IR+ME+ +L L++ L P F+
Sbjct: 99 PPEIGDFAFVTDN-TYTKHQIRQMEMKILRALNFGLGRPLPLHFL 142
>pdb|2JGZ|B Chain B, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 260
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 29/105 (27%), Positives = 53/105 (50%), Gaps = 4/105 (3%)
Query: 78 VAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAAKMEETV 137
+ W+++VQ + L T Y++V+ +DRF+ + +P QL+ V + +A+K EE
Sbjct: 40 IDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKM---LQLVGVTAMFIASKYEEMY 96
Query: 138 VPSLLDLQVEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI 182
P + D + IR+ME+ +L L++ L P F+
Sbjct: 97 PPEIGDFAFVTDN-TYTKHQIRQMEMKILRALNFGLGRPLPLHFL 140
>pdb|3G33|B Chain B, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|D Chain D, Crystal Structure Of Cdk4CYCLIN D3
Length = 306
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 43/172 (25%), Positives = 70/172 (40%), Gaps = 5/172 (2%)
Query: 51 ERNFVPGFDYLTRFQTHSLDASAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRR 110
E +VP Y Q + R+ W+L+V L++NY+DR+L
Sbjct: 49 EERYVPRASYFQCVQ-REIKPHMRKMLAYWMLEVCEEQRCEEEVFPLAMNYLDRYLSC-- 105
Query: 111 LPDNNGWPWQLLSVACLSLAAKMEETVVPSLLDLQVEGAKYIFETKTIRRMELLVLSVLD 170
+P QLL C+ LA+K+ ET ++ L + + + +R E+LVL L
Sbjct: 106 VPTRKAQ-LQLLGAVCMLLASKLRETTPLTIEKLCIY-TDHAVSPRQLRDWEVLVLGKLK 163
Query: 171 WRLRSVTPFSFIYFFACKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
W L +V F+ F +L + A + + +F Y PS
Sbjct: 164 WDLAAVIAHDFLAFILHRLSLPRDRQALVKKHAQTFLALCATDYTFAMYPPS 215
>pdb|2W96|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W99|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9F|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 271
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 15/177 (8%)
Query: 51 ERNFVPGFDYLTRFQTHSLDASAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRR 110
E P Y Q L S R+ W+L+V L++NY+DRFL
Sbjct: 35 EETCAPSVSYFKCVQKEVL-PSMRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEP 93
Query: 111 LPDNNGWPWQLLSVACLSLAAKMEETVVPSLLDLQVEGAKYIFETKTIR-----RMELLV 165
+ + QLL C+ +A+KM+ET+ + L I+ +IR +MELL+
Sbjct: 94 VKKSR---LQLLGATCMFVASKMKETIPLTAEKL------CIYTDNSIRPEELLQMELLL 144
Query: 166 LSVLDWRLRSVTPFSFIYFFACKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
++ L W L ++TP FI F K+ + A + + F+ PS
Sbjct: 145 VNKLKWNLAAMTPHDFIEHFLSKMPEAEENKQIIRKHAQTFVALCATDVKFISNPPS 201
>pdb|2W9Z|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 257
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 15/177 (8%)
Query: 51 ERNFVPGFDYLTRFQTHSLDASAREESVAWILKVQAYYNFLPLTSYLSVNYMDRFLYSRR 110
E P Y Q L S R+ W+L+V L++NY+DRFL
Sbjct: 21 EETCAPSVSYFKCVQKEVL-PSMRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEP 79
Query: 111 LPDNNGWPWQLLSVACLSLAAKMEETVVPSLLDLQVEGAKYIFETKTIR-----RMELLV 165
+ + QLL C+ +A+KM+ET+ + L I+ +IR +MELL+
Sbjct: 80 VKKSR---LQLLGATCMFVASKMKETIPLTAEKL------CIYTDNSIRPEELLQMELLL 130
Query: 166 LSVLDWRLRSVTPFSFIYFFACKLDPTGTFMGFLISRATKIILSNIQEASFLEYRPS 222
++ L W L ++TP FI F K+ + A + + F+ PS
Sbjct: 131 VNKLKWNLAAMTPHDFIEHFLSKMPEAEENKQIIRKHAQTFVALCATDVKFISNPPS 187
>pdb|1W98|B Chain B, The Structural Basis Of Cdk2 Activation By Cyclin E
Length = 283
Score = 41.2 bits (95), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/105 (28%), Positives = 53/105 (50%), Gaps = 7/105 (6%)
Query: 80 WILKVQAYYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPWQLLSVACLSLAAKMEETVVP 139
W+++V Y T YL+ ++ DR++ ++ + QL+ ++ L +AAK+EE P
Sbjct: 56 WLMEVCEVYKLHRETFYLAQDFFDRYMATQE--NVVKTLLQLIGISSLFIAAKLEEIYPP 113
Query: 140 SLLDLQ--VEGAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFI 182
L +GA I MEL+++ L WRL +T S++
Sbjct: 114 KLHQFAYVTDGA---CSGDEILTMELMIMKALKWRLSPLTIVSWL 155
>pdb|3B5O|A Chain A, Crystal Structure Of A Cadd-Like Protein Of Unknown
Function (Npun_f6505) From Nostoc Punctiforme Pcc 73102
At 1.35 A Resolution
pdb|3B5P|A Chain A, Crystal Structure Of A Cadd-Like Protein Of Unknown
Function (Npun_f6505) From Nostoc Punctiforme Pcc 73102
At 2.00 A Resolution
Length = 244
Score = 32.3 bits (72), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 20/56 (35%), Positives = 28/56 (50%), Gaps = 4/56 (7%)
Query: 138 VPSLLDLQVE---GAKYIFETKTIRRMELLVLSVLDWRLRSVTPFSFIYFFACKLD 190
V SL D QV+ GA Y E +I + L+V +++W P YFF+ LD
Sbjct: 127 VLSLFDRQVDYVLGATYAIEATSIPELTLIV-KLVEWLHEGAIPKDLQYFFSKHLD 181
>pdb|1XHX|A Chain A, Phi29 Dna Polymerase, Orthorhombic Crystal Form
pdb|1XHX|B Chain B, Phi29 Dna Polymerase, Orthorhombic Crystal Form
pdb|1XHX|C Chain C, Phi29 Dna Polymerase, Orthorhombic Crystal Form
pdb|1XHX|D Chain D, Phi29 Dna Polymerase, Orthorhombic Crystal Form
pdb|1XHZ|A Chain A, Phi29 Dna Polymerase, Orthorhombic Crystal Form, Ssdna
Complex
pdb|1XHZ|B Chain B, Phi29 Dna Polymerase, Orthorhombic Crystal Form, Ssdna
Complex
pdb|1XHZ|C Chain C, Phi29 Dna Polymerase, Orthorhombic Crystal Form, Ssdna
Complex
pdb|1XHZ|D Chain D, Phi29 Dna Polymerase, Orthorhombic Crystal Form, Ssdna
Complex
pdb|1XI1|A Chain A, Phi29 Dna Polymerase Ssdna Complex, Monoclinic Crystal
Form
pdb|1XI1|B Chain B, Phi29 Dna Polymerase Ssdna Complex, Monoclinic Crystal
Form
pdb|2EX3|A Chain A, Bacteriophage Phi29 Dna Polymerase Bound To Terminal
Protein
pdb|2EX3|C Chain C, Bacteriophage Phi29 Dna Polymerase Bound To Terminal
Protein
pdb|2EX3|E Chain E, Bacteriophage Phi29 Dna Polymerase Bound To Terminal
Protein
pdb|2EX3|G Chain G, Bacteriophage Phi29 Dna Polymerase Bound To Terminal
Protein
pdb|2EX3|I Chain I, Bacteriophage Phi29 Dna Polymerase Bound To Terminal
Protein
pdb|2EX3|K Chain K, Bacteriophage Phi29 Dna Polymerase Bound To Terminal
Protein
pdb|2PY5|A Chain A, Phi29 Dna Polymerase Complexed With Single-stranded Dna
pdb|2PY5|B Chain B, Phi29 Dna Polymerase Complexed With Single-stranded Dna
pdb|2PYJ|A Chain A, Phi29 Dna Polymerase Complexed With Primer-Template Dna
And Incoming Nucleotide Substrates (Ternary Complex)
pdb|2PYJ|B Chain B, Phi29 Dna Polymerase Complexed With Primer-Template Dna
And Incoming Nucleotide Substrates (Ternary Complex)
pdb|2PYL|A Chain A, Phi29 Dna Polymerase Complexed With Primer-Template Dna
And Incoming Nucleotide Substrates (Ternary Complex)
pdb|2PZS|A Chain A, Phi29 Dna Polymerase Complexed With Primer-Template Dna
(Post-Translocation Binary Complex)
pdb|2PZS|B Chain B, Phi29 Dna Polymerase Complexed With Primer-Template Dna
(Post-Translocation Binary Complex)
pdb|2PZS|C Chain C, Phi29 Dna Polymerase Complexed With Primer-Template Dna
(Post-Translocation Binary Complex)
pdb|2PZS|D Chain D, Phi29 Dna Polymerase Complexed With Primer-Template Dna
(Post-Translocation Binary Complex)
Length = 575
Score = 28.1 bits (61), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 15/51 (29%), Positives = 27/51 (52%), Gaps = 12/51 (23%)
Query: 71 ASAREESVAWILKVQA--YYNFLPLTSYLSVNYMDRFLYSRRLPDNNGWPW 119
++ +E +AW+LKVQA Y++ L +N+++R NG+ W
Sbjct: 41 GNSLDEFMAWVLKVQADLYFHNLKFAGAFIINWLER----------NGFKW 81
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.323 0.137 0.421
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 8,034,600
Number of Sequences: 62578
Number of extensions: 262431
Number of successful extensions: 530
Number of sequences better than 100.0: 36
Number of HSP's better than 100.0 without gapping: 24
Number of HSP's successfully gapped in prelim test: 12
Number of HSP's that attempted gapping in prelim test: 459
Number of HSP's gapped (non-prelim): 56
length of query: 330
length of database: 14,973,337
effective HSP length: 99
effective length of query: 231
effective length of database: 8,778,115
effective search space: 2027744565
effective search space used: 2027744565
T: 11
A: 40
X1: 16 ( 7.5 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (22.0 bits)
S2: 52 (24.6 bits)